| Education: | Ph.D., Bioengineering, UCSF & UCB, 2001
B.S., Bioengineering, UCB, 1996 |
| Address: | Department of Radiation Oncology
Stanford University School of Medicine
875 Blake Wilbur Dr., CC-G202
Stanford, CA 94305-5847 |
| Phone: | (650) 723-5591 |
| Fax: | (650) 498-4015 |
| E-mail: | egraves@stanford.edu |
| Research Interests: | I am interested in the development and application of molecular imaging techniques towards understanding radiation and cancer biology and improving treatment of human disease. My current research centers on engineering of hypoxia imaging and conformal radiotherapy methods for small animals to study tumor radiobiology and to devise treatment strategies for clinical translation. |
| Current Labs: | Imaging Radiobiology Laboratory
|
| Recent Publications: |
- La TH, Filion EJ, Turnbull BB, Chu JN, Lee P, Nguyen K, Maxim P, Quon A, Graves EE, Loo BW Jr, Le QT. Metabolic Tumor Volume Predicts for Recurrence and Death in Head-and-Neck Cancer. Int J Radiat Oncol Biol Phys.2009; (): in press.
- Cecic I, Chan DA, Sutphin PD, Ray P, Gambhir SS, Giaccia AJ, Graves EE. Oxygen sensitivity of reporter genes: implications for preclinical imaging of tumor hypoxia. Journal of Molecular Imaging.2007; 6(4): 219-228.
- Graves EE, Giaccia AJ. Imaging Tumoral Hypoxia: Oxygen Concentrations and Beyond. Oncology.2007; 21(3): 368-378.
- Graves EE, Quon A, Loo BW. RT_Image: An Open Source Tool for Investigating PET in Radiation Oncology. Technology in Cancer Research and Treatment.2007; 6(2): 111-121.
- Lee P, Weerasuriya DK, Lavori PW, Quon A, Hara W, Maxim PG, Le QT, Wakelee HA, Donington JS, Graves EE, Loo BW Jr. Metabolic tumor burden predicts for disease progression and death in lung cancer. Int J Radiat Oncol Biol Phys.2007; 69(2): 328-33.
- Catalaa I, Henry R, Dillon WP, Graves EE, McKnight TR, Lu Y, Vigneron DB, Nelson SJ. Perfusion, Diffusion and Spectroscopy Values in Newly Diagnosed Cerebral Gliomas. NMR in Biomedicine.2006; 19(4): 463-475.
- Graves EE, Yessayan D, Turner G, Weissleder R, Ntziachristos V. Validation of in vivo fluorochrome concentrations measured using fluorescence molecular tomography. Journal of Biomedical Optics.2005; 10(4): .
- Li X, Vigneron DB, Cha S, Graves EE, Crawford F, Chang SM, Nelson SJ. Relationship of MR-Derived Lactate, Mobile Lipids, and Relative Blood Volume
for Gliomas in Vivo. American Journal of Neuroradiology.2005; 26(4): 760-769.
- Graves EE, Culver JP, Ripoll J, Weissleder R, Ntziachristos V. Singular Value Analysis and Optimization of Experimental Parameters in Fluorescence Molecular Tomography. Journal of the Optical Society of
America.2004; 21(2): 231-241.
- Graves EE, Weissleder R, Ntziachristos V. In Vivo Molecular Imaging Using Fluorescent Reporters (Review). Current Molecular Medicine.2004; 4(4): 419-430.
- Ntziachristos V, Schellenberger EA, Ripoll J, Yessayan D, Graves E, Bogdanov
A, Josephson L, Weissleder R. Visualization of antitumor treatment by means of fluorescence molecular tomography with an annexin V-Cy 5.5 conjugate. PNAS USA.2004; 101(33): 12294-99.
- Graves EE, Ripoll J, Weissleder R, Ntziachristos V. A Sub-Millimeter Resolution Fluorescence Molecular Imaging
System for Small Animal Imaging. Medical Physics.2003; 30(5): 901-11.
- Kircher MF, Allport JR, Graves EE, Love V, Josephson L, Lichtman AH,
Weissleder R. In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic T-lymphocyte trafficking to tumors. Cancer Research.2003; 63(20): 6838-6846.
- Graves EE, Pirzkall A, McKnight TR, Vigneron DB, Larson DA, Verhey LJ, McDermott M, Chang S, Nelson SJ. Use of Proton Magnetic Resonance Spectroscopic Imaging Data for Planning Focal Radiation Therapies. Image Analysis and Stereology.2002; 21(2): 69-76.
- McKnight TR, von dem Bussche MH, Vigneron DB, Lu Y, Berger MS, McDermott MW, Dillon WP, Pirzkall A, Graves EE, Nelson SJ. Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presence. Journal of Neurosurgery.2002; 97(4): 794-802.
|
view all
|
